Nanotech Commercialization Conference, April 9-10, 2013, Wake Forest Biotech Place, Winston-Salem, NC  www.nanoevent.org $150 registration Fee

Organized by:

Please Join Us at the 5th Annual

Nanotech Commercialization Conference

* * *

April 9-10, 2013

Wake Forest Biotech Place

Winston-Salem, NC

$150 Registration Fee

The 5th Annual Nanotech Commercialization Conference is the preeminent nanotechnology conference to be held in the South this year.

Nanotech innovators, cutting-edge start-ups, leading researchers, public policy leaders and visionaries will be in attendance.

Featured Speakers Include . . .

Prof. David L. Carrol   Ph.D. Director Nanotechnology & Molecular Materials,  Wake Forest University

David L. Carroll, Ph.D.

Director, Nanotechnology &

Molecular Materials,

Wake Forest University

www.wfu.edu

Prof. Carroll is a is a U.S. physicist and nanotechnologist, Fellow of the Society of Nanoscience and Nanotechnology, and Director of the Center for Nanotechnology and Molecular Materials at Wake Forest University

A complete bio

can be found here.

Scott Livingston

Chairman and CEO of Livingston Securities LLC

www.Livingstonsecurities.com

Mr. Livingston has been working on emerging technologies at Wall Street firms for over 18 years and has specialized in nanotechnologies since 2002. Mr. Livingston is the creator of the annual “Livingston Nanotechnology Conference,” the largest annual nanotechnology investor conference since 2005.

A complete bio

can be found here.

XXX

Jim Phillips

Chairman, CEO

NanoMech

www.nanomech.biz

Mr. Phillips is credited with being very instrumental in launching instant messaging, the PDA, Cable Modem, PCS, Fixed Cellular, Time Magazine’s Medical Invention of the Year- the VeinViewer, and iPix, at the time, the world’s largest provider of digital imaging infrastructure for the Internet, in such areas as on-line real estate, auction listings, and classified ads.

A complete bio

can be found here

William P. Moffitt (Bill)  President and CEO, Nanosphere, Inc

William P. Moffitt (Bill)

President and CEO, Nanosphere, Inc

www.nanosphere.us

Mr. Moffit has 35 years of experience in the diagnostics and medical device industry, and has spent the last 20 years developing novel technologies into products and solutions that have helped shape the industry.

A complete bio

can be found here.

xxx

Sally Tinkle, Ph.D.

Deputy Director,

National Nanotechnology Coordination Office

www.nano.gov/about-nni/nnco

Dr. Tinkle is the Deputy Director of the National Nanotechnology Coordination Office of the National Science and Technology Council. Her responsibilities include facilitation and coordination of the National Nanotechnology Initiative, especially the environment, health, and safety activities.

A complete bio

can be found here.

Anthony Atala, M.D.

Director, Professor and Chair –

Wake Forest University

www.wfu.edu

Dr. Atala is the Director of the Wake Forest Institute for Regenerative Medicine, and the W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University.  Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine.  His current work focuses on growing new human cells, tissues and organs.

A complete bio

can be found here

Scott E. Rickert, Ph.D.

Co-founder, President and CEO, Nanofilm

www.nanofilmtechnology.com

Dr. Rickert is among the earliest pioneers in the field of nanotechnology. His knowledge and deep experience in nanotechnology commercialization has made him a trusted advisor to a variety of industries, government entities, organizations and policy development groups.

A complete bio

can be found here.

Douglas W. Jamison

Chairman, CEO and Managing Director,

Harris & Harris Group, Inc.

www.hhvc.com

Mr. Jamison has served as Chairman and Chief Executive Officer since January 2009;  He is a Co-Editor-in-Chief, Journal of Nanotechnology Law & Business and Co-Chair of the Advisory Board, Converging Technology Bar Association and a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board.

A complete bio

can be found here.

Lynn L. Bergeson

Managing Director, Bergeson & Campbell, P.C. (B&C)

www.lawbc.com

Lynn L. Bergeson is Managing Director of Bergeson & Campbell, P.C. (B&C), a Washington, D.C. law firm focusing on conventional and nanoscale industrial, agricultural, and specialty chemical product regulation and approval matters, environmental health and safety law, chemical product litigation, and associated business counseling and litigation issues

A complete bio

can be found here

To see a complete list of Conference speakers please click here.

To see the agenda, please click here.

8-Hour OEHS Mini Boot Camp

April 8, 2013

Pre-Conference Accelerated Training

Training Tomorrow’s OEHS Professionals Today

Wake Forest Biotech Place

Click Here to Register

Official Conference Hotel Accommodations

Winston-Salem Marriott

425 North Cherry Street

Winston-Salem, NC  27101

Toll-free: 800-888-9762

Special Rate:  $124/night

Click Here to Reserve Your Room

Please contact Vincent Caprio with any additional questions in regard to sponsorship or speaking opportunities: vincent@nanobca.org.

________________________________________________________

About NanoBCA: The NanoBusiness Commercialization Association, founded in 2001 as the “NanoBusiness Alliance,” is the first nonprofit association focused on the commercialization of nanotechnologies. Through an extensive network of leading start-ups, Fortune 500 companies, research institutions, NGOs and public-private partnerships, the Association shapes national nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations. The NanoBusiness Commercialization Association is based in Washington, D.C. and Shelton, CT.

About COIN: Established in 2009 in North Carolina, the Center of Innovation for Nanobiotechnology (COIN) is a nonprofit, virtual center of innovation commercialization for nanobiotechnology and nanomedicine. COIN fosters commercialization at the convergence of nano (advanced materials) and bio (life sciences) by providing structured access to relevant resources impacting the field. COIN is a premier source of networking opportunities, information, and tailored innovation services that address client needs and catalyze and advance commercialization of nanobiotechnology.

About The North Carolina Office of Science and Technology: The North Carolina Office of Science and Technology, a division of the North Carolina Department of Commerce, encourages, promotes, and supports scientific, engineering, and industrial research applications in North Carolina.  The mission of the Office is to improve the economic wellbeing and quality of life of all North Carolinians through advancing science, technology, and innovation.  The Office is focused on accelerating North Carolina’s next generation of technology and technology companies. The Office investigates new areas of emerging science and technology and studies the competitiveness of North Carolina industry and research institutions in these fields. The Office also works with the North Carolina General Assembly and the Governor to put into place the infrastructure that keeps North Carolina on the cutting edge of science and technoloy.